BAT-1306

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameBAT-1306
Drug Alias NameBAT-1306
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumoursStomach NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesBio-Thera Solutions Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesBio-Thera Solutions LtdSun Yat-Sen University
Active IndicationsN/A
Inactive IndicationsSolid tumoursStomach NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A